Regeneron Pharmaceuticals Inc REGN
(Start of Section) | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|
| Chiffre d'affaires | 100,00% | 100,00% | 100,00% | 100,00% | 100,00% |
|---|
| Coût des recettes | 9,95% | 13,18% | 15,17% | 12,82% | 13,84% |
|---|
| Marge brute | 90,05% | 86,82% | 84,83% | 87,18% | 86,16% |
|---|
| SG&A | 23,33% | 15,84% | 11,35% | 17,38% | 20,06% |
|---|
| Recherche et développement | 38,62% | 32,19% | 18,09% | 29,51% | 33,84% |
|---|
| Marge d'exploitation % | 28,10% | 42,09% | 55,67% | 41,03% | 32,27% |
|---|
| Net Int, Inc and Other | 58,99% | 86,94% | 113,69% | 80,94% | 64,29% |
|---|
| Marge EBT | 30,89% | 44,84% | 58,03% | 39,91% | 32,01% |
|---|
| 2019 | 2020 | 2021 | 2022 | 2023 |
|---|
| Taux d'imposition | 3,98% | 3,50% | 7,78% | 4,28% | 1,87% |
|---|
| Marge nette | 26,91% | 41,35% | 50,25% | 35,64% | 30,14% |
|---|
| Retour sur actif | 15,94 | 21,98 | 37,91 | 15,88 | 12,69 |
|---|
| Levier financier | 1,34 | 1,56 | 1,36 | 1,29 | 1,27 |
|---|
| Retour sur fonds propres | 21,32 | 31,77 | 54,21 | 20,94 | 16,26 |
|---|